Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders.
about
The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.Psychosocial interventions for people with both severe mental illness and substance misuseSupported employment for adults with severe mental illnessPsychosocial interventions for people with both severe mental illness and substance misuseSupporting good practice in the provision of services to people with comorbid mental health and alcohol and other drug problems in Australia: describing key elements of good service models.Dual diagnosis clients' treatment satisfaction - a systematic review.The influence of treatment attendance on subsequent aggression among severely mentally ill substance abusersIntegrating mental health and addictions services to improve client outcomes.Nicotine dependence in the mental disorders, relationship with clinical indicators, and the meaning for the user.The effectiveness of integrated treatment in patients with substance use disorders co-occurring with anxiety and/or depression--a group randomized trial.Treatment guidelines for substance use disorders and serious mental illnesses: do they address co-occurring disorders?Beyond the limitations of best practices: how logic analysis helped reinterpret dual diagnosis guidelines.Dual diagnosis capability in mental health and addiction treatment services: an assessment of programs across multiple state systems.Empirically Based Psychosocial Therapies for Schizophrenia: The Disconnection between Science and PracticeIntegrated treatment of substance use and psychiatric disorders.Role of social support and self-efficacy in treatment outcomes among clients with co-occurring disorders.Technology-Based Interventions for Substance Use and Comorbid Disorders: An Examination of the Emerging Literature.Factors Associated With Outpatient Visit Attendance After Discharge From Inpatient Psychiatric Units in a New York City Hospital.Care coordination experiences of people with disabilities enrolled in medicaid managed care.The use of antidepressant medications in substance abuse treatment: the public-private distinction, organizational compatibility, and the environment.From Clozapine to Cognitive Remediation.Mental health indicator interaction in predicting substance abuse treatment outcomes in nevada.Cardiometabolic health nursing to improve health and primary care access in community mental health consumers: baseline physical health outcomes from a randomised controlled trial.Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus.Practical outpatient pharmacotherapy for alcohol use disorder.Does transinstitutionalization explain the overrepresentation of people with serious mental illnesses in the criminal justice system?Sixteen-year predictors of substance use disorder diagnoses for patients with mental health disorders.Using NIATx strategies to implement integrated services in routine care: a study protocol.Hidden Drug Abuse in Hong Kong: From Social Acquaintance to Social Isolation
P2860
Q22242826-00F92CE5-F56B-4E5F-8D14-EF4369C0DB6BQ24197576-3BAF9AD7-81C6-4202-BFD2-BF2D902791ABQ24198083-4B684119-00AD-4598-AD8F-B762219415DEQ24242339-51FB40DF-6127-4B52-B96A-251FBD5CB6E2Q30396945-8480FF9D-41B1-49AC-84BF-981FD4803ACEQ33875954-4CB69FBB-801D-45B4-9C37-7C5F9E890BFFQ34243478-B1860CD6-E3DC-47D7-8562-900FE1896837Q34373311-94F80EA2-D035-46C9-B5A9-8DB690F60C47Q34935349-ADEE2CA2-C80B-4D2E-A6BB-5A8EC8680546Q35111694-BEBEE916-11CE-4F33-81F1-F5A22D5026D7Q35774893-6448F564-7D9C-4259-B5FD-C50F74F77DF3Q36542180-3324CF69-F5F7-4A7F-8F1A-D20C48C13E43Q36674945-24F4522F-5706-46E1-8980-E2CB8C84F992Q36848735-B58F38DF-EAC9-4EDC-B0EC-AF0C2B4B685AQ37120179-FF4360B5-43D8-4A00-BC6D-EF267585B045Q37366254-10FB6188-CA75-4550-92C3-23C6ABA6264BQ38687378-7B486CAF-C17C-4554-8679-4C063C54E37CQ39135262-3DD062E0-C1D3-4ADB-BE59-3A6D67FD0880Q39467159-ED2E62A9-2FAB-4DC2-9234-1671A4DDCE31Q40201753-3E6EC4D8-6C73-4A2E-8B0A-E137CAFB8A50Q41904519-8A2AA9CF-6785-49BF-82D2-B5194DDE9A10Q43151727-222D0AB8-31C5-4A52-924E-D644F0CDE79EQ45972177-5820FFDE-63FB-49E8-BB9C-63A843CABAFBQ47569876-D8F49023-CB06-4740-B5C9-2090DC6526C9Q50317988-49C0CC3B-9E24-4114-8CED-76EC9CDBB962Q50625236-E951C4F0-F4D3-49BC-86B2-898FABBF7B16Q51872476-AEEB4A82-1B0D-434F-9251-A031D2153B36Q55411058-912971D1-DDBD-4901-B99E-1C5B698CF803Q57492178-5CDAEBBB-2CDF-403F-A6F5-5FB5B6487685
P2860
Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Integrated versus parallel tre ...... c and substance use disorders.
@en
Integrated versus parallel tre ...... c and substance use disorders.
@nl
type
label
Integrated versus parallel tre ...... c and substance use disorders.
@en
Integrated versus parallel tre ...... c and substance use disorders.
@nl
prefLabel
Integrated versus parallel tre ...... c and substance use disorders.
@en
Integrated versus parallel tre ...... c and substance use disorders.
@nl
P2093
P1476
Integrated versus parallel tre ...... c and substance use disorders.
@en
P2093
Laurel F Mangrum
Molly Lopez
Richard T Spence
P356
10.1016/J.JSAT.2005.10.004
P577
2006-01-01T00:00:00Z